Feng et al., 2018 - Google Patents
Polymeric nanorods with aggregation-induced emission characteristics for enhanced cancer targeting and imagingFeng et al., 2018
- Document ID
- 377385901165796204
- Author
- Feng G
- Mao D
- Liu J
- Goh C
- Ng L
- Kong D
- Tang B
- Liu B
- Publication year
- Publication venue
- Nanoscale
External Links
Snippet
Polymeric nanorods loaded with AIEgens are synthesized via nano-precipitation under ultrasound sonication, where prolonged sonication time could induce a nanodot-to-nanorod transition. These AIE nanorods, but not the nanodots, could be selectively internalized into …
- 239000002073 nanorod 0 title abstract description 118
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Feng et al. | Polymeric nanorods with aggregation-induced emission characteristics for enhanced cancer targeting and imaging | |
| Thambi et al. | Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery | |
| Sahu et al. | Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy | |
| Rao | Shedding light on tumors using nanoparticles | |
| CN102414116B (en) | A supramolecular approach for preparation of size controllable nanoparticles | |
| Xu et al. | Biomedical applications of nanodiamonds: From drug-delivery to diagnostics | |
| Chen et al. | Nanomaterials in medicine and pharmaceuticals: nanoscale materials developed with less toxicity and more efficacy | |
| Zhang et al. | Tailoring the morphology of AIEgen fluorescent nanoparticles for optimal cellular uptake and imaging efficacy | |
| Chen et al. | Glucosamine derivative modified nanostructured lipid carriers for targeted tumor delivery | |
| EP2029119A2 (en) | Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications | |
| US20100209353A1 (en) | Tumor targeting protein conjugate and a method for preparing the same | |
| CN103623430B (en) | A preparation method and application of targeted co-loaded drug delivery system nanoparticles based on polylactic acid-glycolic acid copolymer | |
| Tiwari et al. | Synthesis and bioconjugation of hybrid nanostructures for biomedical applications | |
| Lu et al. | A biocompatible reconstituted high-density lipoprotein nano-system as a probe for lung cancer detection | |
| Li et al. | Dendron‐grafted polylysine‐based dual‐modal nanoprobe for ultra‐early diagnosis of pancreatic precancerosis via targeting a urokinase‐type plasminogen activator receptor | |
| Chen et al. | The preparation of pH and GSH dual responsive thiolated heparin/DOX complex and its application as drug carrier | |
| Hu et al. | Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process | |
| Wang et al. | Lipid coated upconverting nanoparticles as NIR remote controlled transducer for simultaneous photodynamic therapy and cell imaging | |
| He et al. | In situ self-assembly of near-infrared-emitting gold nanoparticles into body-clearable 1D nanostructures with rapid lysosome escape and fast cellular excretion | |
| Sun et al. | NaGdF4: Nd@ NaGdF4 core-shell down-conversion nanoparticles as NIR-II fluorescent probes for targeted imaging of bacteria | |
| WO2013181888A1 (en) | Environmental responsive fundamental copolymer and preparation method therefor | |
| Wang et al. | SWCNT PEG-eggs: Single-walled carbon nanotubes in biocompatible shell-crosslinked micelles | |
| Ruan et al. | Noninvasive in vivo diagnosis of brain glioma using RGD-decorated fluorescent carbonaceous nanospheres | |
| Basu et al. | Recent advancements in the diagnosis and management of cancer using biomaterials-fabricated nanofibers: a review | |
| CN109876150B (en) | Polymer drug carrier, its drug-carrying composition, preparation method and application |